HUTCHMED (HCM) News Today GBX 252 -11.00 (-4.18%) As of 06/13/2025 11:52 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesBuy This Stock HCM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period HCM Makes Bullish Cross Above Critical Moving AverageJune 10, 2025 | nasdaq.comHUTCHMED (LON:HCM) Share Price Passes Below 200-Day Moving Average - Should You Sell?HUTCHMED (LON:HCM) Share Price Crosses Below Two Hundred Day Moving Average - Should You Sell?June 5, 2025 | marketbeat.comHCM: Phase III Study Of Savolitinib Combo Shows Promising Results For EGFR-Mutated NSCLC TreatmentJune 2, 2025 | finanznachrichten.deHUTCHMED (LON:HCM) Share Price Crosses Below Two Hundred Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Stock Price Passes Below 200 Day Moving Average - Here's WhyMay 29, 2025 | marketbeat.comHUTCHMED (LON:HCM) Stock Price Crosses Below 200 Day Moving Average - Time to Sell?HUTCHMED (LON:HCM) Stock Price Passes Below 200 Day Moving Average - Here's What HappenedMay 22, 2025 | marketbeat.comHUTCHMED (LON:HCM) Stock Passes Below 200 Day Moving Average - Time to Sell?HUTCHMED (LON:HCM) Stock Price Crosses Below Two Hundred Day Moving Average - Time to Sell?May 12, 2025 | marketbeat.comHUTCHMED (LON:HCM) Stock Passes Below Two Hundred Day Moving Average - Should You Sell?HUTCHMED (LON:HCM) Share Price Crosses Below Two Hundred Day Moving Average - Here's WhyMay 4, 2025 | marketbeat.comHUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?HUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average - Here's What HappenedApril 25, 2025 | marketbeat.comHUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025April 23, 2025 | uk.finance.yahoo.comHUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average - Here's What HappenedHUTCHMED (LON:HCM) Stock Price Passes Below Two Hundred Day Moving Average - Time to Sell?April 16, 2025 | marketbeat.comHUTCHMED (LON:HCM) Hits New 1-Year Low - Should You Sell?HUTCHMED (LON:HCM) Sets New 12-Month Low - What's Next?April 8, 2025 | marketbeat.comHUTCHMED (LON:HCM) Shares Up 10.3% - What's Next?HUTCHMED (LON:HCM) Shares Up 10.3% - Should You Buy?April 3, 2025 | marketbeat.comHUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average - Should You Sell?HUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average - Time to Sell?March 25, 2025 | marketbeat.comIntended Retirement of Independent Non-executive Directors and changes of composition of board committeesMarch 20, 2025 | markets.businessinsider.comHutchmed/Innovent update on Phase 2/3 study of Fruquintinib+SintilimabMarch 19, 2025 | markets.businessinsider.comHUTCHMED (LON:HCM) Stock Crosses Below 200-Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average - Time to Sell?March 7, 2025 | marketbeat.comHutchmed completes enrollment of fanregratinib trialMarch 6, 2025 | markets.businessinsider.comHUTCHMED (LON:HCM) Stock Price Passes Below 200 Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Stock Crosses Below 200-Day Moving Average - Here's WhyFebruary 28, 2025 | marketbeat.comHUTCHMED (LON:HCM) Share Price Passes Below Two Hundred Day Moving Average - What's Next?HUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average - Here's WhyFebruary 18, 2025 | marketbeat.comHUTCHMED (LON:HCM) Shares Pass Below 200-Day Moving Average - What's Next?HUTCHMED (LON:HCM) Shares Cross Below 200-Day Moving Average - Here's WhyJanuary 31, 2025 | marketbeat.comHutchmed delays circular on $608 million joint venture saleJanuary 28, 2025 | msn.comHUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average - Here's What HappenedHUTCHMED (LON:HCM) Shares Cross Below Two Hundred Day Moving Average - Should You Sell?January 23, 2025 | marketbeat.comHUTCHMED (LON:HCM) Shares Cross Below 200-Day Moving Average - What's Next?HUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average - Here's What HappenedJanuary 15, 2025 | marketbeat.comHUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLCJanuary 13, 2025 | markets.businessinsider.comHutchmed price target lowered to $26 from $30 at BofAJanuary 7, 2025 | markets.businessinsider.comPrivate equity firms are HUTCHMED (China) Limited's (LON:HCM) biggest owners and were rewarded after market cap rose by UK£120m last weekJanuary 5, 2025 | finance.yahoo.comChinese regulators accept NDA for Orpathys/Tagrisso comboJanuary 2, 2025 | msn.comHutchmed divests 45% interest in Shanghai Hutchison for $608MJanuary 1, 2025 | markets.businessinsider.comHUTCHMED Announces US$608 million Divestment of Non-Core Joint VentureJanuary 1, 2025 | markets.businessinsider.comHUTCHMED Divests 45% Stake In Shanghai Hutchison Pharmaceuticals For $608 MlnJanuary 1, 2025 | markets.businessinsider.comHUTCHMED to divest 45% stake in JV with Shanghai PharmaJanuary 1, 2025 | msn.comHUTCHMED (LON:HCM) Stock Crosses Below Two Hundred Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?December 20, 2024 | marketbeat.comHUTCHMED (China) Limited: HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA (fruquintinib)December 13, 2024 | finanznachrichten.deHUTCHMED (LON:HCM) Shares Down 3.7% - Here's What HappenedHUTCHMED (LON:HCM) Shares Down 3.7% - Should You Sell?December 12, 2024 | marketbeat.comHUTCHMED: ORPATHYS And TAGRISSO Get Breakthrough Therapy Designation In China For NSCLCDecember 12, 2024 | markets.businessinsider.comHUTCHMED Receives NMPA Conditional Approval For TYVYT Combination In Advanced Endometrial CancerDecember 4, 2024 | markets.businessinsider.comHUTCHMED (China) Limited: HUTCHMED Announces Launch by Takeda of FRUZAQLA (fruquintinib) in JapanNovember 22, 2024 | finanznachrichten.deHUTCHMED To Receive Milestone Payment As Takeda Launches FRUZAQLA For Colorectal Cancer In JapanNovember 22, 2024 | markets.businessinsider.comHUTCHMED (LON:HCM) Share Price Passes Below Two Hundred Day Moving Average - Here's WhyHUTCHMED (LON:HCM) Share Price Passes Below 200 Day Moving Average - What's Next?November 16, 2024 | marketbeat.comHutchmed to receive $20M milestone payment from Takeda for Fruzaqla salesOctober 31, 2024 | markets.businessinsider.comHUTCHMED (LON:HCM) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?HUTCHMED (LON:HCM) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyOctober 26, 2024 | marketbeat.comHUTCHMED (LON:HCM) Shares Pass Above 200-Day Moving Average - Time to Sell?HUTCHMED (LON:HCM) Stock Crosses Above 200 Day Moving Average - What's Next?October 16, 2024 | marketbeat.comHUTCHMED (China) Ltd (HCM) (Q2 2024) Earnings Call Highlights: Strong US Sales Propel Growth ...October 9, 2024 | finance.yahoo.comHUTCHMED (LON:HCM) Share Price Crosses Above 200 Day Moving Average of $284.47HUTCHMED (LON:HCM) Stock Crosses Above Two Hundred Day Moving Average of $284.47September 28, 2024 | marketbeat.comHUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by TakedaSeptember 24, 2024 | markets.businessinsider.comHutchmed Share Chat (HCM)September 20, 2024 | lse.co.ukHUTCHMED (LON:HCM) Stock Crosses Below 200 Day Moving Average of $281.77HUTCHMED (LON:HCM) Shares Pass Below Two Hundred Day Moving Average of $281.77September 4, 2024 | marketbeat.comHUTCHMED (China) Limited: HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in ChinaAugust 31, 2024 | finanznachrichten.deHUTCHMED (LON:HCM) Stock Crosses Below Two Hundred Day Moving Average of $280.85HUTCHMED (LON:HCM) Shares Cross Below 200-Day Moving Average of $280.85August 27, 2024 | marketbeat.comRobust Sales and Expansion Potential Underpin Buy Rating for HUTCHMEDAugust 5, 2024 | markets.businessinsider.com Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address HCM Media Mentions By Week HCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼-0.640.89▲Average Medical News Sentiment HCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼11▲HCM Articles Average Week Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITH News Today GRI News Today INDV News Today BMY News Today OGN News Today GPH News Today IGC News Today ARTL News Today AURA News Today PHAR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HCM) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HCM Stock Free HCM Stock Alerts